Publikationen (45) Publikationen, an denen Forscher/innen teilgenommen haben

2016

  1. A model for active and healthy ageing with a rare genetic disease: Cystic fibrosis

    European Respiratory Journal, Vol. 47, Núm. 3, pp. 714-719

  2. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

    Clinical and Translational Allergy, Vol. 6, Núm. 1

  3. Analgesia basada en infusión continua de anestésico local a nivel interfascial tras cirugía de colon laparoscópico: Ensayo clínico

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 63, Núm. 4, pp. 197-206

  4. Análisis de coste-utilidad de un modelo de atención integrada a pacientes pluripatológicos basado en un ensayo clínico

    Gaceta Sanitaria, Vol. 30, Núm. 5, pp. 352-358

  5. Association of social support, functional status, and psychological variables with changes in health-related quality of life outcomes in patients with colorectal cancer

    Psycho-Oncology, pp. 891-897

  6. Ausencia de influencia de los niveles de ansiedad o depresión en la calidad de vida, tras intervención de prótesis de cadera o rodilla

    Revista argentina de clínica psicológica, Vol. 25, Núm. 1, pp. 91-98

  7. Chronic obstructive pulmonary disease subtypes. transitions over time

    PLoS ONE, Vol. 11, Núm. 9

  8. Colorectal cancer health services research study protocol: The CCR-CARESS observational prospective cohort project

    BMC Cancer, Vol. 16, Núm. 1

  9. Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain

    Expert Opinion on Orphan Drugs, Vol. 4, Núm. 6, pp. 567-575

  10. Cost-effectiveness analysis of simeprevir with daclatasvir for non-cirrhotic genotype-1b-naïve patients plus chronic hepatitis C

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 16, Núm. 2, pp. 285-294

  11. Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C

    Economía y salud: boletín informativo, Núm. 86

  12. Cost-effectiveness analysis of sofosbuvir-simeprevir regimens for chronic hepatitis C genotype 1 patients with advanced fibrosis

    Medicina Clinica, Vol. 146, Núm. 2, pp. 61-64

  13. Cytotoxicity of Au, ZnO and SiO2 NPs using in vitro assays with mussel hemocytes and gill cells: Relevance of size, shape and additives

    Nanotoxicology, Vol. 10, Núm. 2, pp. 185-193

  14. DG connect funded projects on information and communication technologies (ICT) for old age people: Beyond Silos, CareWell and SmartCare

    Journal of Nutrition, Health and Aging, Vol. 20, Núm. 10, pp. 1024-1033

  15. Determinants of change in physical activity during moderate-to-severe copd exacerbation

    International Journal of COPD, Vol. 11, pp. 251-261

  16. Development of a Telemetric System for Postoperative Follow-up of Vascular Surgery Procedures: In Vitro Model

    Journal of the American Heart Association, Vol. 5, Núm. 7

  17. Economic evaluation of the breast cancer screening programme in the Basque Country: Retrospective cost-effectiveness and budget impact analysis

    BMC Cancer, Vol. 16, Núm. 1

  18. Effectiveness of a strategy that uses educational games to implement clinical practice guidelines among Spanish residents of family and community medicine (e-EDUCAGUIA project): A clinical trial by clusters

    Implementation Science, Vol. 11, Núm. 1

  19. Exfumadores espontáneos. Factores predictores de éxito para abandonar el hábito tabáquico. Revisión sistemática

    DOLOR, Vol. 31, Núm. 4, pp. 135-141

  20. Factors related to a decline in upper extremity function among patients with a wrist fracture due to a fall

    International Journal of Clinical Practice, Vol. 70, Núm. 11, pp. 930-939